Related references
Note: Only part of the references are listed.Energy metabolism disorders and potential therapeutic drugs in heart failure
Yanan He et al.
ACTA PHARMACEUTICA SINICA B (2021)
The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure
Nathalia Fonseca Nadur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Zebrafish Heart Failure Models
Suneeta Narumanchi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Sirt3 increases CNPase enzymatic activity through deacetylation and facilitating substrate accessibility
Dongfang Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Molecular cloning and characterization of an atypical butyrylcholinesterase-like protein in zebrafish
Keai Sinn Tan et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2021)
Generating viable mice with heritable embryonically lethal mutations using the CRISPR-Cas9 system in two-cell embryos
Yi Wu et al.
NATURE COMMUNICATIONS (2019)
2',3'-Cyclic-nucleotide 3'-phosphodiesterase contributes to epithelial-mesenchymal transition of lens epithelial cells through the notch signalling pathway
Yue Li et al.
CELL PROLIFERATION (2019)
Zebrafish heart failure models: opportunities and challenges
Xingjuan Shi et al.
AMINO ACIDS (2018)
Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands
Zhikuan Zhang et al.
CELL REPORTS (2018)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes
Kevin S. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2′,3′-Cyclic nucleotide 3′-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging
Yulia Baburina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Sept7b is required for the subcellular organization of cardiomyocytes and cardiac function in zebrafish
Surjya Narayan Dash et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease
Muneer G. Hasham et al.
DISEASE MODELS & MECHANISMS (2017)
Renal 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase Is an Important Determinant of AKI Severity after Ischemia-Reperfusion
Edwin K. Jackson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Structural and functional evolution of 2′,3′-cyclic nucleotide 3′-phosphodiesterase
Matti Myllykoski et al.
BRAIN RESEARCH (2016)
2′,3′-cAMPI, 3′-AMP, 2′-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors
Elizabeth A. Newell et al.
BRAIN RESEARCH (2015)
Mitochondrial 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors
Yulia Baburina et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) and its roles in activated microglia in vivo and in vitro
Lijuan Yang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Enriched environment induces higher CNPase positive cells in aged rat hippocampus
Yuan-yu Zhao et al.
NEUROSCIENCE LETTERS (2013)
In Vivo Cardiovascular Pharmacology of 2′,3′-cAMP, 2′-AMP, and 3′-AMP in the Rat
Edwin K. Jackson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Expression of the 2′,3′-cAMP-adenosine pathway in astrocytes and microglia
Jonathan D. Verrier et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Ca2+-dependent permeability transition regulation in rat brain mitochondria by 2′,3′-cyclic nucleotides and 2′,3′-cyclic nucleotide 3′-phosphodiesterase
Tamara Azarashvili et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Is the failing heart energy starved? On using chemical energy to support cardiac function
JS Ingwall et al.
CIRCULATION RESEARCH (2004)
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
C Lappe-Siefke et al.
NATURE GENETICS (2003)
Share Paper
